INTRODUCTION {#SEC1}
============

Gene rearrangement is a phenomenon in which a programmed DNA recombination event occurs during cellular differentiation to reconstitute a functional gene from gene segments separated in the genome. The most studied cases of gene rearrangement are the antigen receptor (immunoglobulin and T-cell receptor) genes in vertebrate lymphocytes ([@B1],[@B2]). The coding-sequences for the variable regions of the antigen receptor are split into V (variable), D (diversity), and J (joint) segments. In developing lymphocytes, the V(D)J segments are combined through DNA recombination reactions, depending on RAG1/RAG2 (recombination-activating genes) ([@B3],[@B4]) and DNA repair proteins ([@B2],[@B5]--[@B10]). This process generates antigen receptor diversity that allows adaptive immune defense against a large variety of pathogens. Gene rearrangement also plays crucial developmental roles in prokaryotes: nitrogen fixation in heterocysts of the cyanobacterium *Anabaena* spp. ([@B11]--[@B13]) and sporulation in spore-forming bacteria ([@B14]--[@B22]).

Sporulation-specific gene rearrangement was first reported in *Bacillus subtilis sigK*, which encodes a sporulation-specific sigma factor K (σ^K^) ([@B14]). *sigK* is disrupted into two segments by the insertion of *skin* (*sigK*-intervening element), which is considered a remnant of the ancestral prophage ([@B19]). During sporulation, *skin* is excised from the chromosome to combine the ORFs in frame ([@B14]--[@B16],[@B18]). Many other examples of sporulation-specific gene rearrangement, in addition to *sigK*, suggest that this phenomenon is wide-spread and common in spore-forming bacteria ([@B20]). In a previous study, we found that SPβ, an 'active' prophage, generates a gene rearrangement of *spsM* ([s]{.ul}pore [p]{.ul}olysaccharide [s]{.ul}ynthesis M) in *B. subtilis* strain 168 ([@B21]). In addition to phage particle formation during the lytic cycle, the prophage is also excised from the genome to reconstitute *spsM*, which is essential for production of the spore surface polysaccharides (Figure [1A](#F1){ref-type="fig"}). The SPβ prophage divides *spsM* \[encoding a 341 amino-acids (aa) protein\] into two segments: 5΄-*spsM* (formerly *yodU*; 140 aa) and *spsM*-3΄ (formerly *ypqP*; 207 aa). The overlapping 16 bp nucleotide sequences 'ACAGATAAAGCTGTAT' (translated into 'TDKAV') are found in the 5΄-*spsM* and *spsM*-3΄ (Figure [1B](#F1){ref-type="fig"}). This implies that DNA recombination occurs within the sequences, although the precise position is unclear. The *spsM* rearrangement requires *sprA* and *sprB* in the prophage region ([@B21]). *sprA* is annotated to encode a putative phage integrase ([Supplementary Figure S1A and B](#sup1){ref-type="supplementary-material"}) ([@B23]), which is controlled by the housekeeping sigma factor (σ^A^)-dependent promoter and is constitutionally expressed, regardless of cell status ([@B21],[@B24]). *sprB*, encoding a protein of 58 aa in size ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}), is under the control of the stress-responsible (σ^A^) and sporulation-specific (σ^E/K^) promoters, which are induced during the lytic cycle and sporulation, respectively.

![SPβ excision and *spsM* rearrangement. (**A**) Diagram of SPβ prophage excision in *B. subtilis* 168. In the lytic cycle, the excised SPβ DNA is incorporated into the phage capsids to produce the virion and the host cell undergoes lysis. During sporulation, the prophage excision generates functional *spsM*, which is necessary for production of the spore surface polysaccharides. (**B**) Nucleotide sequences of the junctions prior and posterior to DNA recombination ([@B21]). The 16 bp overlapping nucleotide sequence is indicated in red. Deduced amino-acids sequences are shown above or below the nucleotide sequences.](gkx466fig1){#F1}

SprA is a 545 aa protein with a significant homology to the large serine recombinase (LSR) family proteins. LSRs are 450--700 aa proteins, containing a ∼130 aa catalytic domain (N-terminal domain, NTD) and a 300--500 aa DNA-binding domain (C-terminal domain, CTD) ([@B25]--[@B29]). The NTDs of the LSRs are very similar to that of a well-studied serine resolvase encoded by the transposable element γδ ([@B25],[@B30]). The LSRs bind to their target DNA molecules as dimers, which are formed through NTD-NTD interactions ([@B26],[@B30]--[@B32]). A serine residue within the NTD acts as a nucleophile to attack the phosphate group in the DNA backbone of the *att* core upon DNA cleavage ([@B26],[@B27],[@B31]--[@B33]). The CTD is responsible for DNA-binding properties ([@B34]--[@B37]) and can be subdivided into a recombinase domain (RD) and a zinc-ribbon domain (ZD) to recognize the nucleotides proximal and distal to the *att* core, respectively ([@B38]). Phage-encoded LSRs catalyze site-specific recombination between the phage and host DNA ([@B26],[@B27],[@B29]). An LSR dimer binds to the specific nucleotide sequences in the phage DNA (phage attachment site; *attP*) and host chromosome (bacterial attachment site; *attB*). The *attP*-LSR and *attB*-LSR subunits associate to form a tetrameric complex, called a synaptic complex. In the synaptic complex, cleavage and exchange of the DNA strands occur. Subsequently, *attL* and *attR*: the hybrids of *attP* and *attB*, are generated in the chromosome of the lysogen. Conversely, LSRs require a recombination directionality factor (RDF) for the excision reaction between the *attL* and *attR* sites ([@B26],[@B39]--[@B46]). RDFs are typically small proteins, and they do not share any common motifs ([@B41]).

In the past, temperate phages that are integrated into the host genomes were considered to be in a dormant state. However, recent reports have described gene regulations mediated by prophages, such as the *spsM* rearrangement, in various bacterial species ([@B47]--[@B51]). This is called 'active lysogeny', and the bacteriophage research field regards this as a novel and significant interaction between phage and host ([@B52]). To date, the molecular basis and regulation of active lysogeny are poorly understood. In this study, we established an *in vitro* system for *spsM* rearrangement and revealed the structures of the *att* sites. We also characterized the DNA-recombinase complex formation by electrophoretic mobility shift assay (EMSA) and atomic force microscopic (AFM) observations. Combined with *in vivo* data, our study deciphers the mechanism of active lysogeny at the molecular level for the first time.

MATERIALS AND METHODS {#SEC2}
=====================

Bacterial strains and growth conditions {#SEC2-1}
---------------------------------------

Bacterial strains and plasmids used in this study are listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. Primers used in this study are shown in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}. *Escherichia coli* DH 5α \[New England BioLabs (NEB), MA, USA\] and BL21 SHuffle T7 Expressing *lysY* (NEB) harboring plasmids were grown routinely in Luria-Bertani (LB) medium in the presence of 50 or 100 μg/ml ampicillin. Sporulation of *B. subtilis* was induced by cultivation at 37°C in Difco sporulation medium (DSM) with shaking.

Expression and purification of proteins tagged with six histidines at the C-termini {#SEC2-2}
-----------------------------------------------------------------------------------

*sprA* and *sprB* genes were amplified by PCR with the primer sets, P1/P2 and P3/P4, respectively. PCR products were digested with *Nde*I and *Xho*I, and cloned into the *Nde*I--*Xho*I site of pET22b(+) vector (Merck Millipore, MW, USA) to obtain pET-sprA~WT~ and pET-sprB. To generate pET-sprA~S22A~, mutations in pET-sprA~WT~ were introduced by inverse PCR using the primer set P5/P6, and by self-ligation of the PCR product using the seamless ligation cloning extract (SLiCE) method ([@B53]). *Escherichia coli* cells harboring the expression vectors were grown to the exponential phase \[optical density at 600 nm (OD~600~) = 0.5\] at 30°C in LB medium containing 100 μg/ml ampicillin. Recombinant proteins were induced by addition of 0.5 mM IPTG at 22°C for 20 h (for SprA and SprA~S22A~) and at 30°C for 3 h (for SprB). Harvested cells were lysed in a solution containing 50 mM sodium phosphate (pH 8.0), 0.3 M NaCl, 10 mM imidazole, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM dithiothreitol (DTT), 1 × FastBreak reagent (Promega, WI, USA) and 0.1 mg/ml DNase I. Cell lysate was clarified by a brief centrifugation and loaded into HisTrap HP columns (GE Healthcare, NJ, USA). The recombinant proteins were eluted with a buffer containing 50 mM sodium phosphate (pH 8.0) and 500 mM imidazole, and further purified using HiTrap Q and HiTrap SP columns (GE Healthcare). SprA was loaded into the HiTrap SP column and eluted with 200 mM NaCl. SprB was loaded into the HiTrap Q column and eluted with 100 mM NaCl. Concentrations of the protein samples were measured using a Bradford quantification kit (BioRad, CA, USA).

Preparation of DNA substrates for the *in vitro* recombination assay {#SEC2-3}
--------------------------------------------------------------------

The DNA substrates shown in Figures [2C](#F2){ref-type="fig"}, [2D](#F2){ref-type="fig"}, [3B](#F3){ref-type="fig"}, [7](#F7){ref-type="fig"}, and [Supplementary Figure S9](#sup1){ref-type="supplementary-material"} were generated by PCR using the chromosomal DNA from the *B. subtilis* 168 vegetative and sporulating cells and the primer sets P7/P3 for *attP* (346 bp), P8/P9 for *attB* (828 bp), P8/P3 for *attL* (446 bp) and P7/P9 for *attR* (728 bp) substrates.

![*In vitro* recombination assays. (**A**) Preparation of recombinant SprA and SprB. Recombinant SprA and SprB tagged with the six histidines at their C-termini were purified by affinity chromatography. Purified SprA (2 μg) and SprB (1 μg) were separated by SDS-PAGE (10% gel) and Tricine-SDS-PAGE (16.5% gel), respectively. (**B**) Schematic representation of the SPβ integration/excision reaction. Triangles point to the DNA cleavage sites during the recombination. Thick lines indicate regions corresponding to the DNA substrates for *in vitro* recombination. (**C**) Integration reaction. For *attB* and *attP*, 20 nM of each substrate were reacted with SprA (0, 0.1, 0.2, 0.4, 0.5, 0.6, 0.8 or 1.0 μM) at 37°C for 60 min. Reaction products were separated by 2% agarose gel electrophoresis. (**D**) Excision reaction. For *attL* and *attR*, 20 nM of each substrate were reacted with SprA (0 or 0.5 μM) and SprB (0, 0.25, 0.5, 0.75, 1.0, 1.5, 2.0 or 2.5 μM) at 37°C for 60 min. The reaction products were loaded on a 2% agarose gel. +/--, presence or absence of SprA (0.5 μM) or SprB (2.5 μM). (**E**) Alignment of amino-acid sequences of the NTDs of the LSRs. The nucleophilic serine residue (S) is indicated by the box. (**F**) Impact of a substitution of the 22nd serine with alanine. *In vitro* integration/excision recombination assays were performed using wild-type and mutated SprA (0.5 μM) and SprB (1.0 μM). (-), absence of SprA; WT, wild-type SprA; S22A, SprA~S22A~.](gkx466fig2){#F2}

![DNA cleavage and strand exchange by SprA. (**A**) Direct sequencing of the intermediates of the SprA-mediated integration reaction. The intermediates: the left and right half-sites of *attP*, were directly sequenced using a BigDye Terminator v3.1 Cycle Sequencing Kit and an ABI 3500 DNA analyzer. The 16 bp overlapping sequence is underlined. The 3΄-end nucleotides indicated by the circles are adenines added by the terminal transferase activity of Taq polymerase used for the cycle sequencing reaction. The cleavage point of *attP* is shown to the left (indicated by the lines and triangles). (**B**) Effects of point mutations of the central dinucleotides on DNA recombination. Point mutations were introduced into the AAA nucleotides at the center of the *attB* site (A→T). *In vitro* integration recombination was performed using 0.5 μM SprA and 50 ng each of the wild-type *attP* and the mutated *attB* substrates.](gkx466fig3){#F3}

Introduction of mutations into the *attB* and *attP* substrates {#SEC2-4}
---------------------------------------------------------------

The 828 bp *attB* and 346 bp *attP* DNA fragments were cloned into the pMD20 vector (pMD-B and pMD-P). The point mutations at the core dinucleotides shown in Figure [3B](#F3){ref-type="fig"} and [Supplementary Figure S3](#sup1){ref-type="supplementary-material"} were introduced into pMD-B and pMD-P by inverse PCR using the primer sets P10/P11--P26 and P27/P28--P42, respectively. The PCR products were self-ligated using the SLiCE method. The mutated *attP* and *attB* substrates were amplified from the resulting plasmids with the primer sets P7/P3 and P8/P9, respectively. The *attP* and *attB* substrates of differing lengths, shown in Figure [4](#F4){ref-type="fig"} and [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}, were amplified from the 346 bp *attP*, 828 bp *attB*, 446 bp *attL*, and 728 bp *attR* substrates with the appropriate primer sets: P43--P50/P58--P65 (for *attP*), P74--P80/P88--P94 (for *attB*), P73--P80/P59--P65 (for *attL*), and P44--P50/P87--P94 (for *attR*). DNA fragments containing the *attP* (3,015 bp), *attB* (3,190 bp), *attL* (3,221 bp), and *attR* (2,984 bp) sites were amplified from *B. subtilis* vegetative and sporulating cells using the primer sets P100/P101 (for *attP*), P102/P103 (for *attB*), P101/P7102 (for *attL*), and P100/P103 (for *attR*). The *attP, attB, attL* and *attR* fragments containing deletions from either the right- or left-hand side were generated by PCR using the primers: P45--P49/P106 (for the *attP* left-hand side deletion), P107/P60--P64 (for *attP* right), P75--P79/P104 (for *attB* left), P105/P89--P93 (for *attB* right), P75--P86/P106 (for *attL* left), P105/P61--P72 (for *attL* right), P46--P57/P104 (for *attR* left) and P107/P87--99 (for *attR* right).

![Determination of the minimal *att* sites. (**A**) Evaluation of the recombination activities of the various-sized *att* substrates. Each ∼50 ng of 40--60 bp DNA fragments containing the *att* sites with progressive deletion from both ends were reacted with 0.5 μM SprA in the presence of 50 ng of the ∼3 kb DNA fragments containing the intact partner *att* sequences (*attP*, 3,015 bp; *attB*, 3,190 bp; *attL*, 3,221 bp; *attR*, 2,984 bp). Nucleotide sequences of the short *att* substrates are shown in (**B**). Schematic of the recombination reaction is illustrated in [Supplementary Figure S4](#sup1){ref-type="supplementary-material"}. Numbers above the panels indicate the sizes of the short *att* fragments. SprA (--) indicates the absence of SprA. (**B**) Nucleotide sequences of the minimal *att* sites. Nucleotide sequences of the four *att* sites are shown with their positions. The positions of −1 and +1 are assigned to the central nucleotides of the *attP* site. The minimal *att* sites are indicated by shading. The 16 bp consensus sequences are indicated by boxes. Arrows and asterisks denote the inverted repeat sequences and the mismatched nucleotides within the *attP* sites, respectively. The deletion series of the short *att* substrates were shown as below: *attP*60, from −30 to +30; *attP*54, −27 to +27; *attP*52, −26 to +26; *attP*50, −25 to +25; *attP*48, −24 to +24; *attP*46, −23 to +23; *attP*44, −22 to +22; *attB*48, −24 to +24; *attB*46, −23 to +23; *attB*44, −22 to +22; *attB*42, −21 to +21; *attB*40, −20 to +20; *attB*38, −19 to +19; *attB*36, −18 to +18; *attL*54, −25 to +29; *attL*50, −23 to +27; *attL*48, −22 to +26; *attL*46, −21 to +25; *attL*44, −20 to +24; *attL*42, −19 to +23; *attL*40, −18 to +22; *attR*54, −29 to +25; *attR*50, −27 to +23; *attR*48, −26 to +22; *attR*46, −25 to +21; *attR*44, −24 to +20; *attR*42, −23 to +19; *attR*40, −22 to +18.](gkx466fig4){#F4}

*In vitro* recombination assays {#SEC2-5}
-------------------------------

Unless otherwise noted in the Figure legends, 20 nM of the DNA substrates, 0.5 μM SprA, and 1 μM SprB were reacted at 37°C for 60 min in 10 μl of the reaction solution containing 10 mM Tris--HCl (pH 8.0), 20 mM NaCl, and 0.1 mM DTT. The recombination reaction was stopped by the addition of 0.1% SDS and by heat treatment at 60°C for 3 min. Reaction products were separated by agarose gel electrophoresis. Signals were detected using EZ-Vision DNA Dye (AMRESCO, OH, USA).

Mapping of the *attP* cleavage site {#SEC2-6}
-----------------------------------

PCR for a 2231 bp DNA fragment harboring the *attP* site was performed using the chromosomal DNA of the *B. subtilis* 168 sporulating cells and the P100/P108 primers. Two microgram of the PCR product were mixed with 0.3 μM SprA in 100 μl of the reaction solution containing 10 mM Tris--HCl (pH 8.0), 20 mM NaCl and 0.1 mM DTT. The reaction mixture was incubated at 37°C for 12 h in the presence of 30% ethylene glycol and 5% glycerol to accumulate the cleavage products ([@B54]). The cleavage products were treated by proteinase K, extracted by phenol, and precipitated using 100% ethanol. DNA pellets were dissolved in TE buffer, gel purified, and directly sequenced using the P107 (for the left half*-*site of *attP*) or P109 (for the right half*-*site) primers, a BigDye^®^ Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific, WI, USA) and an ABI 3500 DNA analyzer (Thermo Fisher Scientific).

Electrophoresis mobility shift assays {#SEC2-7}
-------------------------------------

DNA fragments containing the *att* sites were amplified with the primer sets P110/P61 (for *attP*; 89 bp), P111/P87 (for *attB*; 106 bp), P111/P58 (for *attL*; 111 bp), and P7/P87 (for *attR*; 132 bp). The second PCR was performed using a digoxigenin (DIG)-labeled primer P112 and a reverse primer: P61 (for *attP*), P87 (for *attB* and *attR*), or P58 (for *attL*). The second PCR products had additional five nucleotides (TCGTA) at 5΄-ends derived from the P112 primer. Non-labeled 232 bp *attP* and 237 bp *attL* fragments were amplified with the primer sets P7/P106 and P8/P58, respectively. Binding reaction mixtures containing 10 mM Tris--HCl (pH 7.5), 20 mM NaCl, 0.1 mM DTT, 0.1 mg/ml poly dIdC·dIdC (GE Healthcare), 10 nM probes, 0 or 20 nM non-labeled DNA, 0--0.4 μM SprA, and 0--12.8 μM SprB were incubated at 37°C for 30 min and separated by native-PAGE (4% polyacrylamide, 0.5 × TBE, 4°C, 5 W, 2 h). The gel after the electrophoresis was capillary-blotted onto a nylon membrane for 6 h using 10 × SSC. Signals were detected using anti-DIG antibody conjugated to alkaline phosphatase (Roche, Mannheim, Germany) and nitro-blue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate (NBT/BCIP; Roche).

Atomic force microscopy (AFM) {#SEC2-8}
-----------------------------

The *attL* and *attR* fragments amplified with the primers P113/P114 and P107/P115 were combined using an overextension PCR method. The resulting 1098 bp DNA (4.8 nM), SprA (0.5 μM) and SprB (1.6 μM) were reacted at 37°C for 15 min in 10 μl of the reaction solution containing 10 mM Tris--HCl (pH8.0), 20 mM NaCl and 0.1 mM DTT. AFM was performed in air with the tapping mode of a Multimode AFM (Veeco, CA, USA) and an Olympus silicon cantilever (OMCL-AC160TS-W2; Olympus, Tokyo, Japan). Imaging was carried out according to the method described previously ([@B55]) with a slight modification: the glutaraldehyde cross-linking step was omitted. Images were analyzed using the NANOSCOPE software.

Artificial induction of SPβ excision {#SEC2-9}
------------------------------------

BsINDB ([@B21]) was cultured at 37°C in 100 ml of LB medium. When the cells reached the mid-log phase (OD~600~ = 0.5), *sprB* expression was induced by the addition of 0.25 mM IPTG. Three hours after the addition of IPTG, cells were harvested and washed twice with 100 ml of fresh LB medium. Cell pellets were resuspended with 100 ml of fresh LB medium and divided into two parts: one part was further cultured at 37°C in the presence of 0.25 mM IPTG and the other part was in the absence of IPTG. One milliliter of the culture was harvested hourly after the addition of IPTG. Chromosomal DNA was isolated from the cells, digested with *Nde*I (NEB), and subjected to Southern hybridization with the *spsM*-specific probe as described previously ([@B21]).

Detection of SPβ reintegration during sporulation {#SEC2-10}
-------------------------------------------------

To construct a *B. subtilis* BSIID strain carrying the P*~spoIID~--sprB* construct, pMUT-sprBind plasmid vector ([@B21]) was linearized by inverted PCR using the primer set P116/P117. A DNA fragment containing the *spoIID* promoter region was amplified from *B. subtilis* chromosomal DNA with the primer set P118/P119. The linearized vector and the insert DNA were ligated using the SLiCE method. The resulting plasmid harboring the P*~spoIID~--sprB* construct, pMUT-IID, was introduced into *B. subtilis* 168 via natural competence and integrated at the *sprB* locus through a single crossing-over event. The transformants carrying the P*~spoIID~--sprB* construct were selected on LB-agar plates containing 0.3 μg/ml erythromycin. The 168-AEB and BSIID-AEB strains carrying an ectopic *attB* site at the *amyE* locus were generated by transformation of *B. subtilis* 168 and BSIID with an *amyE*-integration vector harboring an intact *spsM* gene, pMFspsM ([@B21]). The 168-AEB and BSIID-AEB strains were induced to sporulation by cultivation at 37°C in 5 ml of liquid DSM. Chromosomal DNA was isolated from the sporulation cells at T~0~ and T~8~. To detect the reintegration, PCR was performed using 100 ng of chromosomal DNA with a combination of the *sprB*-specific primer P116 and the *amyE*-specific primer P120. Sporulating cells at T~24~ were negatively stained with Indian ink and observed by phase-contrast microscopy as described previously ([@B21]).

RT-PCR {#SEC2-11}
------

*B. subtilis* 168 and BSIID cells were cultured at 37°C in 300 ml of liquid DSM. Every hour, 20 ml of the culture was harvested by centrifugation from T~0~ until T~8~. Total RNA was extracted according to the previously described method ([@B56]). A reverse transcription reaction was performed using 1 μg of total RNA, RevertAID reverse transcriptase (Thermo Fisher Scientific), and the *sprB*-specific primer P121. The *sprB* cDNA was amplified by 20 cycles of PCR using Prime Taq (Genet Bio, Chungnam, Korea) and the primer set P116/P121. PCR products were analyzed using 2% agarose gel electrophoresis.

RESULTS {#SEC3}
=======

Site-specific DNA recombination catalyzed by SprA and SprB {#SEC3-1}
----------------------------------------------------------

In a previous study, we identified *sprA* and *sprB* to be essential factors for *spsM* rearrangement. SprA contains three distinct domains of the LSRs: NTD, RD and ZD ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}), and thus is expected to play the central role in *spsM* rearrangement. SprB is likely to be the genetic switch for *spsM* rearrangement because *sprB* expression correlates with phage excision ([@B21]). To elucidate the site-specific recombination activity, *sprA* and *sprB* were cloned into the pET22b(+) expression vector. Recombinant SprA and SprB with six histidines fused to their C-termini were expressed in *E. coli*. Purified SprA and SprB migrated at approximately 62 kDa in SDS-PAGE (10% gel) and at 8.5 kDa in Tricine-SDS-PAGE (16.5% gel), respectively (Figure [2A](#F2){ref-type="fig"}). The 828 bp *attB* and 346 bp *attP* substrates (Figure [2B](#F2){ref-type="fig"}; 20 nM each) were reacted with the various concentrations of SprA at 37°C for 60 min and analyzed by agarose gel electrophoresis. Signals indicating the recombination products \[*attL* (446 bp) and *attR* (728 bp)\] were detected when more than 0.4 μM of SprA was added to the reactions (Figure [2C](#F2){ref-type="fig"}, lanes 4--8) while SprB was not required for the integration reaction. The conversion rate of the substrates to the recombinant products did not reach 100%. A similar case to this observation was reported in ϕC31 Int-mediated recombination ([@B57]).

We next examined the excision reaction. The 446 bp *attL* and 728 bp *attR* substrates (20 nM) were reacted with 0.5 μM SprA in the presence of various concentrations of SprB. Figure [2D](#F2){ref-type="fig"} shows that excision products appeared when the molar ratio of SprB to SprA was 1: 1 (Figure [2D](#F2){ref-type="fig"}, lane 4), and that the excision occurred efficiently when the ratio was more than 2:1 (lanes 6--9). Neither SprA nor SprB alone could catalyze the excision reaction (lanes 2 and 10). A single serine residue at the NTD of LSR is the nucleophile that cleaves the DNA strand ([@B26]). Alignments of the LSR amino-acids sequences disclosed that the 22nd residue of SprA was the nucleophile serine (Figure [2E](#F2){ref-type="fig"}, box). A serine-to-alanine substitution at the 22nd residue caused a loss of the integration/excision activities (Figure [2F](#F2){ref-type="fig"}, S22A). These results confirmed that SprA and SprB are an LSR and cognate RDF, respectively. The quantitative relationship between SprA and SprB for efficient excision (Figure [2D](#F2){ref-type="fig"}) implies that SprB may behave as a multimer, or at least a dimer, to promote the excision reaction. Consistent with this, Gp3, the RDF for *Strepotomyces* ϕBT1 phage integrase, is reported to form a dimer in solution ([@B46]). The requirement for a higher concentration of SprB than SprA for excision likely generates a threshold response of the *spsM* rearrangement. This would avoid unexpected excision in case of the leakage of *sprB* expression beyond the program of gene regulation during sporulation and the lytic cycle.

Mechanism of the *spsM* rearrangement and structure of SPβ *att* sites {#SEC3-2}
----------------------------------------------------------------------

The most significant issues regarding *spsM* rearrangement are how the precise rejoining of the *spsM* segments occurs and why *spsM* is targeted by the SPβ phage. Information on the catalytic features of SprA and the structures of the *attP, attB, attL* and *attR* sites for SPβ are necessary to answer these questions. One of the prominent features of SPβ *att* sites is the conserved sequence of up to 16 bp in the middle of the site (Figure [1B](#F1){ref-type="fig"}) which encodes the amino acids at positions 136--140 of SpsM. Such a long conserved sequence has never been reported in the *att* sites for other LSRs. Recombination was expected to take place within the conserved sequence. Because target DNA recognition and strand exchange are the central steps of the *spsM* rearrangement, we further studied the molecular basis of the precise *spsM* rearrangement and the structures of the *att* sites.

To determine the cleavage site of *attP* during recombination, a DNA fragment containing the *attP* site was reacted with SprA at 37°C overnight in the presence of 30% ethylene glycol and 5% glycerol to allow accumulation of the cleavage products ([@B54]). The sequencing data of the cleavage products suggested that SprA produced the 3΄-overhanging di-adenine nucleotides (AA) at the center of the *attP* site (Figure [3A](#F3){ref-type="fig"} and [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). From the conservation of the central 16 bp nucleotide sequence, the *attB, attL*, and *attR* sites will be cleaved by SprA at the same positions as *attP*. The overhanging dinucleotides originate from the first and second adenines of the lysine codon (AAA) within the 16 bp conserved sequence. To investigate the importance of three adenines for the DNA recombination, we carried out an *in vitro* recombination experiment using mutated *attB* substrates with single point mutations at each of the three adenines (Figure [3B](#F3){ref-type="fig"}). Integration reactions were performed using the mutated *attB* and the wild-type *attP* DNA. The mutated *attB* sites harboring either the TAA or ATA substitution (*attB~TAA~* and *attB~ATA~*) exhibited ∼90% reductions in the recombination efficiencies. By contrast, the *attB~AAT~* site retained the recombination activity at a comparable level to the wild-type *attB* (*attB~AAA~*), indicating that SprA recognized the first and second adenines as the cleavage site but not the entire lysine codon. Efficient DNA recombination was accomplished when the central AA-dinucleotides were changed into T in both the *attP* and the *attB* sites ([Supplementary Figure S3, AA, AT, TA and TT](#sup1){ref-type="supplementary-material"}). This result suggests that the inability of the wild-type *attP* and either of *attB~TAA~* or *attB~ATA~* to recombine resulted from non-complementary overhanging nucleotides, and not from a failure of the target DNA recognition by SprA due to the mutations. We conclude that the base-pairing of the 3΄-overhanging dinucleotides between the substrates is critical for re-joining. Production of 3΄-overhanging dinucleotides is a common catalytic feature of the LSR proteins, although the dinucleotides sequences vary from one recombinase to another ([@B26],[@B31],[@B33],[@B38]). One plausible reason why all of the sporulation gene-intervening elements possess the LSR-encoding gene (e.g. *spoIVCA* in *B. subtilis skin* ([@B15]--[@B18]), *ssrA* in *B. weihenstephanensis vfbin* ([@B20]), Geoth_3268 in *Geobacillus thermoglucosidasius* ([@B20])) may be to carry out precise gene rearrangements in a similar manner to SprA.

Next, we addressed the question of why SPβ targeted the *spsM*-coding region for lysogenization. To examine this, we analyzed the whole structure of the minimal SPβ *att* sites. To determine the minimal size requirements of the *att* sites, we created a series of *att* substrates with progressive deletions from both ends and evaluated their recombination efficiencies. The deletion series (36--60 bp) were reacted with SprA in the presence of ∼3 kb substrates containing the intact partner *att* sites (Figure [4A](#F4){ref-type="fig"}). The minimal *att* sites were defined as the shortest *att* substrates that showed \>90% recombination efficiencies compared with the longest substrates of the deletion series used in this experiment (*attP*, 60 bp; *attB*, 48 bp; *attL*, 54 bp; *attR*, 54 bp). The deletion analysis revealed that the minimal *attP, attB, attL* and *attR* sites were 52, 44, 48 and 48 bp long, respectively. The overall sequences of the *att* sites are described in Figure [4B](#F4){ref-type="fig"}. We also confirmed the minimal size requirements using a series of *att* substrates with progressive deletions from either the left or right half-sites ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). The sizes of the minimal *att* sites for SPβ were comparable to those for other serine recombinases ([@B28]). In general, *attP* sites for LSRs are ∼60 bp nucleotide sequences consisting of inverted repeat sequences that encompass the short conserved sequence, and their partner *attB* sites are ∼48 bp sequences that possess the conserved sequence but have no obvious similarity to *attP* ([@B26]). The minimal *attP* site for SPβ consists of the 16 bp perfect inverted repeat sequence (Figure [4B](#F4){ref-type="fig"}, *attP*, arrows), encompassing the 16 bp conserved sequence (Figure [4B](#F4){ref-type="fig"}, boxed nucleotides). Moreover, the inverted repeat can be extended into the conserved sequence and the *attP* site, and therefore create 25 bp symmetric sequences with respect to the central dinucleotides, which include only three mismatches (Figure [4B](#F4){ref-type="fig"}, *attP*, asterisks). These mismatches may serve as landmarks to distinguish the direction of the *attP* site. A sequence as highly symmetric as the SPβ *attP* site has never been found in other LSRs. Single point mutations to any nucleotides of the 16 bp conserved sequence of the SPβ *attB* site, except the nucleotide at position +9, reduced recombination efficiency ([Supplementary Figure S7](#sup1){ref-type="supplementary-material"}, 61%--89% efficiencies relative to that of the wild-type *attB*). In particular, the mutations at positions -6 (C→A) and +2 (A→C), which are located within the inverted sequence, caused 35% and 39% losses of efficiency, respectively, indicating the importance of these nucleotides for recombination. Nevertheless, the effects of the point mutations on recombination were moderate, compared with the replacement of the AA dinucleotides ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). This suggests that the dinucleotides are critical for recognition by SprA as well as production of the overhanging ends for the precise rejoining reaction. In summary, the *attP* contains a perfect inverted repeat sequence surrounding the central 16 bp region that is identical to that of *attB* within *spsM* (406--421 nt). The central 16 bp region is also conserved in the two other recombination hybrids: *attL* and *attR*. Intriguingly, the conserved region has sequences of inverted symmetry flanking the central AA dinucleotides. As such, the short stretch of symmetric sequences around the AA dinucleotides in *spsM* appears to be favorable for recognition by SprA and would have been selected as the crossover site for the gene rearrangement system.

Analysis of protein-DNA complex formation by EMSA {#SEC3-3}
-------------------------------------------------

To investigate the complex formation of SprA, SprB, and the *att* sites, we carried out an electrophoretic mobility shift assay (EMSA). We examined the SprA-DNA complex formation using the 5΄-DIG-labeled *att* probes. After incubation at 37°C for 30 min, the reaction mixtures were separated by a 4% native acrylamide gel. SprA showed binding activity to all of the *att* probes \[Figure [5A](#F5){ref-type="fig"}, complex I (CI)\]. EMSA showed that SprA was able to bind to the *attL* and *attR* probes without SprB. The estimated dissociation constants (*K*~d~) for the binding of the SprA dimer to the probes were 132 nM (for *attB*), 119 nM (for *attP*), 75 nM (for *attL*) and 70 nM (for *attR*). When the *attP* and *attB* probes were used, fast-migrating faint bands were detected, probably due to complexes of monomeric SprA and DNA (Figure [5A](#F5){ref-type="fig"}, top panels, asterisk). We next studied the formation of the SprA--SprB--DNA complex during excision. The addition of SprB generated super-shifted bands indicating the SprA--SprB-DNA complexes (Figure [5B](#F5){ref-type="fig"}, lanes 7--10, CII), while SprB alone did not exhibit DNA-binding activity (lane 11). SprB directly interacted with SprA ([Supplementary Figure S8](#sup1){ref-type="supplementary-material"}) and formation of the SprA--SprB complex is likely to be the rate-limiting step in the excision reaction because the complex could rapidly generate the excision products ([Supplementary Figure S9, iii](#sup1){ref-type="supplementary-material"}). Bands that migrated faster than the SprA-DNA complex were also observed when SprB was added (Figure [5B](#F5){ref-type="fig"}, lanes 7--10, asterisk). The fast migrating species were also reported in the ϕC31 Int and the RDF complex formation ([@B45]) but their nature is currently unknown. As was the case for the *attL* and *attR* sites, the SprA--SprB complex also exhibited binding activity to the *attP* and *attB* sites ([Supplementary Figure S10](#sup1){ref-type="supplementary-material"}).

![Electrophoretic mobility shift assays (**A**) SprA-DNA complex formation. For these assays, 10 nM of the DIG-labeled *attP* (94 bp), *attB* (111 bp), *attL* (116 bp), and *attR* (137 bp) probes were reacted with the various concentrations of SprA at 37°C for 30 min. SprA concentrations were as follows: 0, 25, 50, 100, 150, 200, 250, 300 and 350 nM. The reaction mixtures were separated by 4% native gels. FP, free probe; CI, SprA--DNA complex. Asterisks indicate SprA monomers bound to DNA. (**B**) SprA--SprB-DNA complex formation. The *attL* and *attR* probes (10 nM) were reacted with 0.4 μM SprA in the presence of 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.4 or 12.8 μM SprB (lanes 3--10). FP, free probe; CI, SprA--DNA complex; CII, SprA--SprB--DNA complex; \*, additional bands of unknown nature; +/−, presence or absence of 0.4 μM SprA and 12.8 μM SprB. (**C**) Synaptic complex formation. Here, 10 nM of each of the *attR* (left panel) and *attB* probes (right panel) were reacted with 0.4 μM SprA~S22A~ in the presence or absence of 3.2 μM SprB and 20 nM non-labeled partner *att* DNA. FP, free probe; CI, SprA-DNA complexes; CII, SprA--SprB-DNA complexes; SC, synaptic complexes; +/−, presence or absence of 0.4 μM SprA~S22A~, 3.2 μM SprB, and 20 nM non-labeled *att* DNA.](gkx466fig5){#F5}

Finally, we examined the synaptic complex formation during excision and integration using the *attR* and *attB* probes. In this experiment, SprA~S22A~ was used instead of wild-type SprA to stabilize the synaptic complex. As shown in Figure [5C](#F5){ref-type="fig"}, the band retarded to a greater extent than the SprA--SprB-*attR* complex was indicative of the synaptic complex, and was detected in the presence of the non-labeled *attL* DNA \[Figure [5C](#F5){ref-type="fig"}, left panel, lane 4, Synaptic Complex (SC)\]. Depletion of SprB in the reaction resulted in the disappearance of the SC band (lane 5), indicating that during excision the synaptic complex depends on SprB. By contrast, synaptic complex formation during integration was accomplished under conditions without SprB (Figure [5C](#F5){ref-type="fig"}, right panel, lane 3, SC). Moreover, addition of SprB abolished the synaptic complex formation between the *attB* and *attP* sites (lane 4), although the SprA--SprB-*attB* complex was still observed (lane 4, CII).

Visualization of the synaptic complex using atomic force microscopy (AFM) {#SEC3-4}
-------------------------------------------------------------------------

We have demonstrated *in vitro* recombination and synaptic complex formation using two separate *att* substrates; however, in practice, the *spsM* rearrangement takes place on a single molecule of the chromosomal DNA *in vivo*. We verified the recombination reaction on a single DNA molecule by AFM imaging. We prepared a 1098 bp DNA substrate that contained the 5΄- and 3΄-portions of the disrupted *spsM* gene (Figure [6A](#F6){ref-type="fig"}). The size of the naked DNA measured from the AFM image was 361 nm in length (Figure [6B](#F6){ref-type="fig"}, [i](#F6){ref-type="fig"}), consistent with the calculation (Figure [6A](#F6){ref-type="fig"}, 372 nm). The DNA substrate was reacted with SprA and SprB at 37°C for 15 min and observed in air by AFM. Panel ii shows the primary complexes without a synapsis of the subunits at the *attL* and *attR* sites. Bright points on the DNA indicate SprA and SprB bound to the *att* sites. The *attL* and *attR* sites were distinguishable by measuring the DNA length from the DNA ends to the SprA--SprB binding positions. Panel iii displays the synaptic complex. The internal region between the *attL* and *attR* sites (representing the SPβ prophage region) appeared to loop out from the complex. After the completion of the excision reaction, the circular DNA with or without SprA (Figure [6B](#F6){ref-type="fig"}, panel iv, top and bottom right) and the linear DNA were observed (Figure [6B](#F6){ref-type="fig"}, panel iv, left). The linear DNA was 233 nm in length, which was consistent with the calculated size of the reconstituted *spsM* (231 nm). When SprA~S22A~ was used for AFM imaging instead of wild-type SprA, the complex containing SprA~S22A~ stopped at the synaptic complex formation and could not proceed due to the defects in the DNA cleavage activity (Figure [6B](#F6){ref-type="fig"}, [v](#F6){ref-type="fig"}). These AFM imaging data show each of the steps during the excision *in vitro*, establishing that the *spsM* rearrangement is accomplished by SprA and SprB without any other factors, such as host-encoded nucleoid proteins and DNA repair proteins. This is the first example of visualization of the synaptic complex formation during LSR-mediate DNA recombination.

![AFM imaging of the *spsM* rearrangement. (**A**) Schematic of a 1098-bp DNA substrate for AFM imaging. Size (nm) of the DNA molecule was calculated from one DNA base pair of 0.34 nm in length ([@B68]). (**B**) Representative images at each of the stages during the excision reaction. The DNA substrate (4.8 nM) was incubated with or without SprA (0.5 μM) and SprB (1.6 μM) at 37°C for 15 min and then observed using AFM. The top panels show the AFM images: i, naked DNA; ii, primary complex; iii, synaptic complex; iv, excised SPβ and reconstituted *spsM*; v, the synaptic complex containing SprA~S22A~. Scale bar indicates 125 nm. The bottom panels are illustrations of the AFM images. Actual sizes (nm) of the DNA molecules were measured from AFM images.](gkx466fig6){#F6}

Inhibition of integration by SprB {#SEC3-5}
---------------------------------

EMSA data demonstrated that SprB inhibited synaptic complex formation of the *attB* and *attP* sites (Figure [5C](#F5){ref-type="fig"}, right panel). SprB, thus, was expected to block the integration reaction. To test this, various concentrations of SprB were added into the reactions containing the *attB* and *attP* substrates and SprA. We found that the integrative products disappeared in a SprB-dose-dependent manner (Figure [7](#F7){ref-type="fig"}, lanes 3--8). Signals of the integrative products began to decrease when the ratio of SprB to SprA in the reaction was 2:1 (lane 5), and completely disappeared at the ratio of 4.5:1 (lane 8), suggesting that SprB blocked the integration of SPβ DNA. Combined with the EMSA results (Figure [5C](#F5){ref-type="fig"}), we concluded that SprB inhibited the integration reaction by blocking the synaptic complex formation. Inconsistent with our result, only small amounts of the RDF (one-fourth of the Int concentration) were necessary to inhibit ϕBT1 Int integration activity ([@B46]). In another case, ^mv4^Xis, the RDF for lactococcal phage mv4 tyrosine-type integrase, facilitated excision and integration at the same time ([@B58]). The control mechanism of the recombination directionality may vary from one Int/RDF system to another.

![Inhibition of integration by SprB. The *attP* and normal *attB* substrates (20 nM each) were reacted with 0.5 μM SprA in the presence of the various concentrations of SprB (0, 0.25, 0.5, 1.0, 1.5, 2.0 or 2.5 μM) at 37°C for 60 min.](gkx466fig7){#F7}

Repression of SPβ reintegration by SprB *in vivo* {#SEC3-6}
-------------------------------------------------

Our *in vitro* study showed that SprB has a role in regulating the recombination directionality through promoting and repressing the synaptic complexes during the excision and integration, respectively (Figures [5C](#F5){ref-type="fig"} and [7](#F7){ref-type="fig"}). We therefore evaluated the regulatory effect of SprB on recombination *in vivo*. First, we investigated the control of recombination by SprB in vegetative cells using the BsINDB strain whose *sprB* is under the control of the IPTG-inducible promoter ([@B21]). BsINDB was cultivated in LB medium up to the mid-exponential growth phase, and SPβ excision was induced by the addition of IPTG into the medium. The disrupted or reconstituted *spsM* DNA was detected by Southern blotting using the *spsM*-specific probe (Figure [8A](#F8){ref-type="fig"}). A signal indicating the *spsM* rearrangement appeared 1 h and later after the addition of IPTG \[Figure [8B](#F8){ref-type="fig"}, IPTG (+) 1--6 h, Reconstituted\]. When IPTG was removed from the medium at 3 h, the SPβ DNA was steadily reintegrated into the chromosome \[IPTG (−) 4--6 h\]. This result confirmed that SprB acts as a genetic switch for *spsM* rearrangement.

![Repression of reintegration by SprB. (**A**) A schematic shows the *B. subtilis spsM* locus prior (left) and posterior (right) to the SPβ excision. Black and gray lines represent the *spsM* gene and the SPβ prophage region. N, *NdeI*-recognition sites; thick line, *spsM*-specific probe for Southern blotting. (**B**) Artificial control of SPβ excision and integration. The BsINDB strain harboring an IPTG-inducible *sprB* construct was cultured in the presence and absence of 0.25 mM IPTG, as described in the Materials and Methods section. Chromosomal DNA was extracted from the cells at indicated time points after the addition of IPTG (T = 0 h) and subjected to Southern hybridization. Disrupted, disrupted *spsM* (9 kb); Reconstituted, reconstituted *spsM* (6 kb). (**C**) Transcription of *sprB* during sporulation. Total RNA was isolated from the 168 and BSIID sporulating cells. The *sprB* cDNA was synthesized from 1 μg of total RNA, amplified by 20 cycles of PCR, and analyzed using 1.5% agarose gel electrophoresis. T~0--8~ denote the times after the onset of sporulation. Arrowheads indicate the RT-PCR products of *sprB* (**D**) Effect of a change in *sprB* expression pattern on spore morphology. Spores produced by the strain 168 (Pσ^E/K^*--sprB*) and BSIID (Pσ^E^*--sprB*) cells were negatively stained with Indian ink and observed using phase-contrast microscopy. Arrows indicate spores that lack the polysaccharide layer. (**E**) Schematic of the SPβ reintegration assay. *B. subtilis* strains, 168-AEB (Pσ^E/K^*--sprB*) and BSIID-AEB (Pσ^E^*--sprB*) possess an ectopic *attB* at the *amyE* locus. Reintegration of the excised SPβ into the *amyE* locus was detected by PCR using a combination of the *sprB*- and *amyE*-specific primers. (**F**) Detection of the reintegration. PCR was performed using chromosomal DNA from the 168-AEB and BSIID-AEB cells at T~0~ and T~8~ with the primers shown in the panel E. The arrowhead indicates the PCR product that corresponds to the 3.5 kb region within the *amyE--sprB* locus.](gkx466fig8){#F8}

In *B. subtilis* 168, *sprB* is controlled by the stress-responsible and sporulation-specific promoters. Because the sporulation-specific *sprB* promoter (Pσ^E/K^) is recognized by σ^E^-and σ^K^-containing RNA polymerases, *sprB* is transcribed during the middle-to-late stages of sporulation ([@B21]). We constructed a mutant strain in which the *sprB* promoter was replaced with that of *spoIID* (designated as BSIID). The *spoIID* promoter (Pσ^E^) is recognized by the σ^E^-containing RNA polymerase and is transcribed at the early stage of sporulation ([@B59]). RT-PCR detected the *sprB* transcripts at 4--8 h (T~4~--T~8~) after the onset of sporulation in the wild-type strain (Figure [8C](#F8){ref-type="fig"}, Pσ^E/K^) and at T~2~--T~6~ in BSIID (Pσ^E^). We found a morphological change between the wild-type and BSIID-B spores. All wild-type spores were surrounded by the polysaccharide layer, indicating that *spsM* rearrangement occurred in all the sporulating cells (Figure [8D](#F8){ref-type="fig"}, Pσ^E/K^--*sprB*), while 7.5% of total spores from BSIID-B were lacking the polysaccharide layer (Pσ^E^--*sprB*, arrows).

SPβ excision is essential for *spsM* activation and production of the spore polysaccharide layer in *B. subtilis*. This result implied failure of the excision or reintegration of the excised SPβ DNA in BSIID-B. To verify these possibilities, we introduced an ectopic *attB* site at the *amyE* locus of the wild-type and BSIID strains (designated as 168-AEB and BSIID-AEB, respectively) as shown in Figure [8E](#F8){ref-type="fig"}. Chromosomal DNA from the 168-AEB and BSIID-AEB sporulating cells at T~0~ and T~8~ were isolated to detect the reintegration by PCR with *amyE*- and *sprB*-specific primers. As the result, the *amyE--sprB* fragment was successfully amplified only at T~8~ in BSIID-AEB (Figure [8F](#F8){ref-type="fig"}), indicating that BSIID-AEB retained the SPβ excision activity and that the reintegration event occurred at the late sporulation phase. A quantitative PCR assay showed that reintegration was detected in 2.2% of the BSIID-AEB cells at T~8~ ([Supplementary Figure S11](#sup1){ref-type="supplementary-material"}). The reintegration rate was seemingly lower than the result from the microscopic observation (Figure [8D](#F8){ref-type="fig"}, right panel, 7.5%). This is because BSIID-AEB has two *attB* sites at the *spsM* and *amyE* loci, and BSIID was sampled at a later time point during the culture (T~24~) to obtain mature spores for observation. Sporulation-independent reintegration was also detected in both 168-AEB and BSIID-AEB, but at very low frequencies (∼0.06%), probably due to spontaneous excision during the overnight preculture and exponential growth in the DSM culture. Taken together, these results suggest that continuous expression of *sprB* throughout the sporulation phase is important for the maintenance of the reconstituted *spsM* gene and normal spore formation.

DISCUSSION {#SEC4}
==========

In the present study, we have demonstrated that SprA and SprB are an LSR that acts as the SPβ phage integrase and the cognate RDF, respectively (Figure [2](#F2){ref-type="fig"}). In the *spsM* rearrangement, the 5΄-*spsM* and *spsM*-3΄ segments must be combined in frame. SprA precisely generates the 3΄-overhanging dinucleotides at the center of the *att* site during recombination (Figure [3](#F3){ref-type="fig"}). EMSA and the *in vitro* recombination assay demonstrated that SprB promoted excision while inhibiting integration by controlling synaptic complex formation (Figures [5C](#F5){ref-type="fig"} and [7](#F7){ref-type="fig"}). While typical prophages excised in the lytic cycle are packaged into the new phage particles, the SPβ prophage excised during sporulation is neither packaged into the virion nor reintegrated into the chromosome ([@B21]). Therefore, the control and maintenance of the recombination directionality has profound importance in the *spsM* rearrangement. We showed that depletion of SprB in the late sporulation phase led to failure of spore maturation due to the reintegration of SPβ DNA (Figure [8D](#F8){ref-type="fig"} and [F](#F8){ref-type="fig"}). The *in vivo* data confirmed that SprB triggers phage excision and that the long-term expression of *sprB* is the key factor for maintaining the reconstituted *spsM* during sporulation.

On the basis of our *in vitro* and *in vivo* data, we propose a model for control of the *spsM* rearrangement (Figure [9](#F9){ref-type="fig"}): the SPβ phage integrase, SprA, is employed for the insertion of the phage DNA into the host chromosome upon infection. Even after prophage integration, *sprA* is constitutively expressed in the lysogen; however, it is insufficient for the prophage excision due to a deficit of SprB. When the host enters into the sporulation phase, the *sprB* promoter is induced in the mother cell compartment. Subsequently, the SprA--SprB complex is formed and catalyzes the excision to reconstitute *spsM*. Although the SprA--SprB complex has the ability to bind to the *attP* and *attB* sites, it cannot form the synaptic complex to generate reintegration. Thus, SprB exerts inhibitory effects on the reintegration to ensure the stable expression of functional *spsM* throughout the late stage of the sporulation phase. Transcription of *spsM* might also interfere with SprA binding to *attB*. The functional *spsM* gene is expressed at the late stage to produce the spore surface polysaccharides for the spore maturation. Our report is the first example to show the detailed mechanism of active lysogeny, mediated by RDF expression. The inhibitory effect of RDFs on integration is likely to be a general feature of phage-encoded RDFs for LSRs, as this phenomenon has been reported in the other RDFs such as ϕRv1 Xis ([@B42]) and ϕC31 Gp3 ([@B45],[@B57]). SPβ employs this principle to achieve irreversible active lysogeny for *B. subtilis spsM* by embedding the late-mother-cell-specific promoter upstream of *sprB*. The developmentally-regulated *spsM* gene rearrangement is a good example case to use to explain the irreversible regulation of active lysogeny.

![A model for control of the irreversible regulatory switch for *spsM*. The schematic representation shows morphological changes during sporulation and the *spsM* rearrangement in *B. subtilis* 168. The housekeeping (σ^A^) and sporulation-specific (mother cell, σ^E^→σ^K^; forespore, σ^F^→σ^G^) sigma factors are indicated in the schematic. In the SPβ lysogen, *sprA* is constitutively expressed in the vegetative phase; nevertheless, the excisional recombination does not occur due to the lack of SprB. During sporulation, SprB is expressed from the mid until the late stages and participates in the excision of SPβ prophage. The excised SPβ is prevented from reintegrating because the SprA--SprB complex cannot catalyze the integrative recombination. The inhibitory effect of SprB on reintegration allows the stable expression of functional *spsM* during sporulation. Stoichiometry of SprA and SprB in the complex is not considered in this cartoon.](gkx466fig9){#F9}

Analysis of the structures of the SPβ *att* sites revealed that the 52 bp *attP* comprises an extremely symmetric nucleotide sequence (Figure [4B](#F4){ref-type="fig"}, *attP*). A single nucleotide deletion from the 5΄- or 3΄-end of the minimal *attP* site resulted in the almost complete loss of recombination activity (Figure [4A](#F4){ref-type="fig"} and [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}), suggesting that conservation of the inverted repeat sequence is critical for SprA-medicated recombination. The *attB* site is 44 bp in size, which consists of left and right half-sites of equal length. Unlike *attP*, no obvious symmetry was found between each half-site of *attB*, except for the 16 bp conserved sequence (Figure [4B](#F4){ref-type="fig"}, *attB*). The 16 bp conserved sequence likely plays a crucial role in the catalytic activity of SprA. SprA can generate recombination products effectively only when the *attP* and *attB* sites carry the AA- or TT-central dinucleotides ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). As indicated by the structure of *attP* (Figure [4B](#F4){ref-type="fig"}), the highly symmetric sequence is the key to the target recognition of SprA. The 16 bp conserved sequence within *spsM* is the symmetric sequence that contains the central AA-dinucleotides and, therefore, would be selected as the target for the ancestor of SPβ because of the unique sequence that met the requirements for SprA-catalyzed recombination. SprA might then have adapted to recognize the 44 bp stretch of DNA containing the conserved sequence within *spsM* in the history of evolution. The minimal *attL* and *attR* sites correspond to the hybrids of the minimal *attP* and *attB* sites (Figure [4B](#F4){ref-type="fig"}, *attL* and *attR*). Unexpectedly, when the substrates were 1 nt shorter than the minimal sites, excision occurred at ∼50% efficiency compared to that of the intact *att* sites ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). A possible explanation for this is that the SprA bound to the longer *att* half-site serves to stabilize the DNA-binding of the other through protein-protein interactions. Alternatively, SprB may alter the nucleotide recognition properties of SprA. The *attL* and *attR* sites exhibited no symmetry because of the hybrids between *attP* and *attB*; nevertheless, the 16 bp conserved sequence provides them with a symmetric central region, which would support the binding of an SprA dimer. Such a long conserved sequence is also expected to be beneficial for the precise *spsM* rearrangement in the case of a change in the cleavage point, which may be caused by mutations in SprA.

The mechanism of SprA-mediated gene rearrangement seems to be very similar to mechanisms of recombination reported in other LSRs; however, two significant differences are found: target recognition by SprA and control of phage excision. The minimal size requirements of *attP* and *attB* for SprA are 4--10-bp longer than those for Bxb1 Int (*attP*, 48 bp; *attB*, 38 bp) and ϕC31 Int (*attP*, 39 bp; *attB*, 34 bp) ([@B60]). The central dinucleotides of the *att* sites for ϕBT1 and ϕC31 integrases can be changed between A, T, G and C, although all 16 combinations of the dinucleotides were not examined ([@B61],[@B62]). Inconsistent with this, substitutions of the central dinucleotides of the SPβ *attB* and *attP* sites, especially with G and C, led to a critical loss of efficiency ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). The requirement for the long *att* sites and the preference for the AA dinucleotides would be necessary for SprA to recognize recombination sites and achieve secure reconstitution at the 138th lysine codon (AAA) of *spsM*. Xu and colleagues reported that Bxb1 and ϕC31 integrases efficiently catalyzed site-specific DNA recombination in mouse and human cells, while SprA (referred to as SPBc) showed weaker activity and produced inaccurate recombination in the mammalian cells ([@B63]). SprA may be sensitive to the subcellular environment as well as to the target nucleotide sequence. Another significant difference is the control of phage excision. A requirement of RDF for phage excision is commonly found in phage-encoded LSRs ([@B41]), although they vary in size and amino acid sequence (e.g. Bxb1 RDF, 255 aa; ϕC31 RDF, 244 aa; SprB, 58 aa) ([@B60]). Interestingly, the Bxb1 prophage integrates into the *groEL1* locus of the host genome ([@B64]), whose gene product is known to be necessary for biofilm formation in Mycobacterium; however, Bxb1 lysogens are defects in biofilm formation ([@B65]), suggesting that reconstitution of *groEL1* does not occur. As described above, the developmentally-regulated excision of phage DNA and the maintenance by SprB in the host cell is a unique mechanism found in SPβ.

LSR-mediated site-specific DNA recombinations are being applied to genetic engineering *in vitro* ([@B61],[@B62]) and *in vivo* ([@B66],[@B67]), with the aim of genome engineering for living organisms and gene therapy. However, the currently-devised approaches are mostly based on LSR-mediated 'integration' reactions. Although RDF-mediated excision is a more complicated reaction than integration, it can become available for engineering as well, and will make LSRs into more powerful tools. As an example, the *spsM* rearrangement system, in which the target gene is controlled by the integration/excision of the prophage, is expected to be applied to protein expression systems. Further studies on the mechanism of LSR-mediated excision will be required for a better understanding of the fundamentals of the phage life cycle and future applications.
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